Provided herein are arylsulfonamide salts e.g. a salt of a compound of Formula I which are useful for modulating CCR3 activity and their pharmaceutical compositions. Also provided herein are methods of their use for treating preventing or ameliorating one or more symptoms of a CCR3 mediated disorder disease or condition.